| Literature DB >> 10384886 |
R E Holland1, R A Wilson, M S Holland, V Yuzbasiyan-Gurkan, T P Mullaney, D G White.
Abstract
Strains of Escherichia coli from 101 healthy and 114 diarrheic calves were screened by PCR for the eae (intimin) gene and Shiga toxin genes (stx). Each eae+ and eae/stx+ strain was examined for antimicrobial susceptibility, enterohemolysin activity, and the somatic O antigen was determined. An immunoassay was used to detect Shiga toxin antigens for the eae/stx+ E. coli. Significantly more (p = 0.005) of the healthy calves carried eae+ and eae/stx+ E. coli in their feces when compared to strains from diarrheic calves. Moreover, Shiga toxin antigens were detected significantly more (p = 0.001) often among the eae/stx+ strains from healthy calves when compared to eae/stx+ strains from diarrheic calves. However, significantly more (p = 0.001) of the eae+ and eae/stx+ strains from diarrheic calves were resistant to at least one of the antimicrobials tested, and the strains from diarrheic calves had a significantly (p = 0.05) higher rate of antimicrobial resistance to at least two different antimicrobial classes. No significant difference (p> or =0.05) was detected among the eae+ and eae/stx+ strains from healthy and diarrheic calves for enterohemolysin production. Serogroups O-negative, O5, O26, and O111 were predominate among both healthy and diarrheic calves.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10384886 PMCID: PMC7117348 DOI: 10.1016/s0378-1135(99)00013-9
Source DB: PubMed Journal: Vet Microbiol ISSN: 0378-1135 Impact factor: 3.293
Attributes of the E. coli strains used to validate the PCR and Premier EHEC assays
| Strain ID | Serotype | Source | ||
| ECRC 933 | 0157:H7 | + | + | adult/human |
| MIECb | 0157:H7 | + | + | human |
| C1520–77 | 0157:H7 | + | + | calf |
| AI2198–77 | 0111:H− | + | + | infant/human |
| EL2966–56 | 0111:H2 | + | − | adult/human |
| EF1–50 | 0111:H2 | + | − | adult/human |
| EE3782–62 | 055:H6 | + | − | infant/human |
| EQ5624–50 | 055:H7 | + | − | infant/human |
| 807–13b | 0149:NM | − | − | foal |
| 6131b | 05:NM | + | + | calf |
Obtained from the E. coli Reference Center, Pennsylvania State University.
bPositive control strains (MIEC and 6131) and negative control (807-13) isolated from identified sources in Michigan.
Enterohemolysin, antimicrobial resistance and Shiga-toxin antigens associated with eae+ and eae/stx+E. coli isolated from calves
| Healthy calves | Diarrheic calves | |||||
| Total (%) | Total (%) | |||||
| 20 | 20 | 40 | 12 | 11 | 23 | |
| Enterohemolysin | 10 | 10 | 20 (50.0) | 8 | 4 | 12 (52.2) |
| Single antimicrobial resistance | 4 | 7 | 11 (27.5) | 3 | 5 | 8 (34.8) |
| Multiple antimicrobial resistance | 1 | 8 | 9 (22.5) | 6 | 6 | 12 (52.2) |
| Shiga-toxin antigens | 0 | 20 | 20(100.0) | 0 | 8 | 8 (73.0) |
Displaying resistance to at least two separate antimicrobial classes.
Distribution of eae+ and eae/stx+E. coli among serogroups and relationship to the attaching and effacing lesion
| Serogroup | Healthy calves | Diarrheic calves | |||
| A/E lesion | |||||
| 0 | 9 | 0 | 7 | 1 | 5 |
| 05 | 2 | 8 | 0 | 5 | 2 |
| 06 | 0 | 0 | 1 | 0 | 0 |
| 08 | 1 | 0 | 0 | 1 | 0 |
| 010 | 2 | 0 | 0 | 0 | 0 |
| 026 | 2 | 3 | 2 | 0 | 0 |
| 050 | 1 | 0 | 1 | 0 | 0 |
| 055 | 0 | 0 | 0 | 1 | 1 |
| 069 | 0 | 0 | 0 | 1 | 1 |
| 080 | 0 | 0 | 1 | 0 | 1 |
| 084, 172 | 0 | 1 | 0 | 0 | 0 |
| 098 | 0 | 2 | 0 | 0 | 0 |
| 0103 | 1 | 1 | 0 | 0 | 0 |
| 0111 | 0 | 3 | 0 | 2 | 0 |
| 0118 | 1 | 0 | 0 | 0 | 0 |
| 0156 | 1 | 0 | 0 | 0 | 0 |
| 0157 | 0 | 1 | 0 | 0 | 0 |
| 0171 | 0 | 1 | 0 | 0 | 0 |
| Total | 20 | 20 | 12 | 11 | 10 |
Antimicrobial resistance pattern of eae+ and eae/stx+E. coli from calves
| Antimicrobial | Percent resistant strains | |||
| Healthy ( | Diarrheic ( | |||
| Amikacin | S | S | S | S |
| Ampicillin | 5.0 | 12.5 | 26.0 | 17.4 |
| Ceftiofur | S | S | 4.3 | 13.0 |
| Cephalothin | 2.5 | 2.5 | 13.0 | 22.0 |
| Chloramphenicol | S | S | S | 17.4 |
| Enrofloxacin | S | S | S | S |
| Gentamicin | 7.5 | 10.0 | 4.3 | 30.4 |
| Tetracycline | 17.5 | 20.0 | 26.0 | 35.0 |
| Trimethoprim/sulfamethoxazole | S | S | 13.0 | 17.4 |
| Nalidixic acid | S | S | S | S |
S = Sensitive to the antimicrobial listed.